Analysts' Actions: ARO, DUK, PPG

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Arch Coal ( ACI) was upgraded at Goldman Sachs from Sell. Valuation call, based on an $8 price target, Goldman said.

Assured Guaranty ( AGO) was upgraded at UBS to Buy from Neutral. $18 price target. Favorable risk/reward, UBS said.

Alere ( ALR) was downgraded at Capstone Investments from Buy to Hold. Company lacks near-term visibility, Capstone said.

Aeropostale ( ARO) was upgraded at Wells Fargo to Market Perform. Business trends appear to be improving, Wells Fargo said.

Baker Hughes ( BHI) was downgraded at Societe Generale from Buy to Hold. $47 price target. Company is seeing lower margins in North America, Societe Generale said.

CACI was upgraded from Underweight to Neutral at JP Morgan. $52 price target. Stock has declined 29% since earnings, JP Morgan said.

Carefusion ( CFN) was upgraded at CLSA from Outperform to Buy. Expect strong 2013 guidance from management, CLSA said. $30 price target.

Cinemark ( CNK) was initiated with a Buy rating at Wunderlich. Valuation call, based on a $30 price target.

Duke Energy ( DUK) was upgraded at UBS to Buy from Neutral. $24 price target. Consolidated company creates scale and value creation potential, UBS said.

Eaton Vance ( EV) was upgraded at Citigroup to Neutral from Sell. $23.50 price target. Shares approaching appropriate valuation, Citi said.

Express ( EXPR) was initiated with a Neutral rating at JP Morgan. $20 price target. Company lacks near-term catalysts, JP Morgan said.

1-800-Flowers ( FLWS) was upgraded to Buy at TheStreet Ratings.

Forum Energy ( FET) was initiated with a Buy rating at Deutsche Bank. $30 price target. Company is leveraged to strong secular growth markets, Deutsche said.

Green Dot ( GDOT) was downgraded at Morgan Stanley from Overweight to Equal-weight. $25 price target. Company is facing regulatory and competitive pressures, Morgan Stanley said.

Heico ( HEI) was upgraded at Bank of America/Merrill Lynch to Buy. Valuation call, based on a $54 price target, BofA/Merrill said.

Human Genome ( HGSI) was downgraded at BMO Capital to Market Perform. $13 price target. GSK may drop its bid for the company, BMO Capital said.

Hyatt Hotels Corp. ( H) was downgraded to Hold at TheStreet Ratings.

Knight Transportation ( KNX) was upgraded at Sterne Agee. $17 price target. Estimates were also increased, as the company should perform better over the coming quarters, Sterne Agee said.

National Oilwell Varco ( NOV) was upgraded at Societe Generale from Hold to Buy. $85 price target. Stock has underperformed its peers of late, Societe Generale said.

Onyx Pharmaceuticals ( ONXX) was initiated with an Outperform rating at Bernstein. $74 price target. Carfilzomib should ultimately help drive the company toward profitability, Bernstein said.

PPG Industries ( PPG) was upgraded from Neutral to Buy at Bank of America/Merrill Lynch. $115 price target. Stock has pulled back, and the company should see lower raw material costs, BofA/Merrill said.

RailAmerica ( RA) was downgraded at JP Morgan from Overweight to Neutral. $26 price target. Valuation call, as the stock is already up 61% on the year, JP Morgan said.

Westlake Chemical ( WLK) was upgraded to Neutral from Sell at UBS. $54 price target. Stock is now near its fair price, UBS said.

Watson Pharmaceuticals ( WPI) was upgraded at Wells Fargo from Market Perform to Outperform. Actavis acquisition should create higher earnings power, Wells said.

STOCK COMMENTS / EPS CHANGES

American Eagle ( AEO) numbers were increased at Piper Jaffray. Company boosted its guidance, Piper Jaffray said. Overweight rating and new $24 price target.

BlackRock ( BLK) numbers were lowered at Citigroup. Shares are now seen reaching $180. Estimates were also lowered as secondary absorbed significant demand and few near-term catalysts, Citi said.

Capital One ( COF) was added to Select List at Stifel Nicolaus. Acquisitions should help boost growth, Stifel Nicolaus said. $71 price target.

Eaton Vance ( EV) numbers were cut at BMO. Estimates were reduced through 2013. Company is leveraged to weaker equity market performance, BMO said. Market Perform rating.

Genesco ( GCO) estimates, price target were raised at Sterne Agee. Estimates were boosted through 2014. Company is seeing favorable sales trends, Sterne Agee said. Buy rating and new $85 price target.

Hewlett-Packard ( HPQ) numbers were raised at Sterne Agee. Shares are now seen reaching $33. Estimates were also increased, as management appears to be turning the business around, Sterne Agee said. Buy rating.

Newmont Mining ( NEM) numbers were lowered at Jefferies. Shares are now seen reaching $46. Estimates were also lowered on skepticism over growth projects, Jefferies said. Hold rating.

NetApp ( NTAP) estimates, price target were reduced at Credit Suisse. Shares are now seen reaching $30. Estimates were also cut, given the company's new guidance, Credit Suisse said. Neutral rating.

Ralcorp ( RAH) estimates, price target were reduced at BMO Capital. Shares are now seen reaching $72. Company is seeing lower volume and rising input costs, BMO Capital said. Market Perform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.